Industry Reports
Pfizer Completes Acquisition Of Anacor Pharmaceuticals
Pfizer Inc announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common...
Industry Reports
Bristol-Myers Squibb to Announce Results for Second Quarter 2016 on July 28
Bristol-Myers Squibb Company will announce results for the second quarter of 2016 on Thursday, July 28, 2016. During a conference call at 10:30 a.m. EDT...
Industry Reports
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Peregrine Pharmaceuticals, Inc announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E Convertible Preferred Stock...
Industry Reports
Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting
Merck known as MSD outside the United States and Canada, announced that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, will present an overview of...
Industry Reports
Thunderbolt Pharma, Inc , Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma Inc.
Baxalta Incorporated , Velocity Pharmaceutical Development, LLC and Astellas Pharma Inc announced that Thunderbolt, Inc., a company established by Vitesse Biologics, acquired all rights to...
Industry Reports
Merck Co Inc Announces Third-Quarter 2016 Dividend
Merck announced that the Board of Directors has declared a quarterly dividend of $0.46 per share of the company’s common stock for the third quarter...
Industry Reports
Merck Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition
Healthcare and Life Science drive Group organic sales growth (+4.7%) Sigma-Aldrich acquisition fuels sales (+20.5%) and EBITDA pre exceptionals (+27.0%) Integration of Sigma-Aldrich proceeding...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.